Brooklyn Investment Group Grows Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brooklyn Investment Group raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 2,913 shares of the medical equipment provider’s stock after purchasing an additional 97 shares during the period. Brooklyn Investment Group’s holdings in Intuitive Surgical were worth $1,520,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Hazlett Burt & Watson Inc. increased its holdings in shares of Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. increased its stake in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. Fragasso Financial Advisors Inc increased its stake in Intuitive Surgical by 3.0% in the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after purchasing an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC increased its stake in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares during the last quarter. Finally, Meeder Advisory Services Inc. grew its position in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after buying an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This trade represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $592.64 on Friday. The company has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $597.68. The stock’s 50 day moving average price is $539.54 and its 200 day moving average price is $497.69.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ISRG shares. Robert W. Baird increased their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.